Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NextPlat CorpNXPL · Entity 7521 | Director · Chairman & CEO · 10% owner | October 01, 2024 | October 04, 2024 |
| Progressive Care Inc.RXMD · Entity 108817 | Director · Chairman & CEO · 10% owner | July 01, 2023 | October 20, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NextPlat Corp
Report date October 01, 2024 · Filed October 04, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,576,598 |
Reported balance
After 2024-10-01 transaction · row 1
1 source rowRow 1 · 2024-10-01 · Grant · Acquired 27,145 · Balance 1,576,598 F1: On October 1, 2024, the Reporting Person received 27,145 shares of the Issuer's common stock in exchange for 18,261 shares of Progressive Care Inc. in connection with the merger of Progressive Care Inc. into the Issuer (the "Merger"). On the effective date of the Merger, the Issuer's Per Share Value was $1.48, which is the daily volume weighted average price of the Issuer's common stock for the 20-trading day period ended on the trading day immediately preceding the date of the Merger Agreement on Nasdaq. |
| Common StockSEC Table I · non-derivative | IndirecteAperion Partners LLC | 2,990,252 |
Reported balance
After 2024-10-01 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2024-10-01 · Grant · Acquired 687,038 · Balance 2,990,252 F2: In connection with the Merger, the Reporting Person indirectly received 687,038 shares of the Issuer's common stock in exchange for 462,185 shares of Progressive Care Inc. through eAperion Partners LLC. On the effective date of the Merger, the Issuer's Per Share Value was $1.48, which is the daily volume weighted average price of the Issuer's common stock for the 20-trading day period ended on the trading day immediately preceding the date of the Merger Agreement on Nasdaq. F3: Mr. Fernandez is the sole member and managing partner of eAperion Partners LLC and has voting and dispotive power over the reported shares. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.48 · Expires 2032-09-13 | Direct | 233,682 |
Reported balance
After 2024-10-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-10-01 · Grant · Acquired 233,682 · Balance 233,682 F5: In connection with the Merger, the Report Person received stock options to acquire 233,682 shares of the Issuer's common stock in exchange for stock options to acquire 157,203 shares of Progressive Care Inc. The options are fully vested. |
| Common StockSEC Table I · non-derivative | IndirectSpouse | 25,000 |
Reported balance
Holding disclosure · report date 2024-10-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 25,000 F4: Lauren Sturges-Fernandez |
Filing footnotes · ownership attribution and instrument terms
F1: On October 1, 2024, the Reporting Person received 27,145 shares of the Issuer's common stock in exchange for 18,261 shares of Progressive Care Inc. in connection with the merger of Progressive Care Inc. into the Issuer (the "Merger"). On the effective date of the Merger, the Issuer's Per Share Value was $1.48, which is the daily volume weighted average price of the Issuer's common stock for the 20-trading day period ended on the trading day immediately preceding the date of the Merger Agreement on Nasdaq.
F2: In connection with the Merger, the Reporting Person indirectly received 687,038 shares of the Issuer's common stock in exchange for 462,185 shares of Progressive Care Inc. through eAperion Partners LLC. On the effective date of the Merger, the Issuer's Per Share Value was $1.48, which is the daily volume weighted average price of the Issuer's common stock for the 20-trading day period ended on the trading day immediately preceding the date of the Merger Agreement on Nasdaq.
F3: Mr. Fernandez is the sole member and managing partner of eAperion Partners LLC and has voting and dispotive power over the reported shares.
F4: Lauren Sturges-Fernandez
F5: In connection with the Merger, the Report Person received stock options to acquire 233,682 shares of the Issuer's common stock in exchange for stock options to acquire 157,203 shares of Progressive Care Inc. The options are fully vested.
Progressive Care Inc.
Report date July 01, 2023 · Filed October 20, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy eAperion Partners LLC | 1,557,356 |
Reported balance
After 2023-07-01 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2023-07-01 · Other · Acquired 228,240 · Balance 1,557,356 F8: Includes 18,261 shares of common stock directly held by the Reporting Person; 1,071,251 shares of common stock held indirectly by NextPlat Corp., of which the Reporting Person is the Chief Executive Officer; and 239,604 shares of common stock held indirectly by eAperion Partners LLC, of which the Reporting person is the sole member and managing member. F7: The Reporting Person is the sole member and managing member of eAperion Partners LLC. |
| Common StockSEC Table I · non-derivative | IndirectBy eAperion Partners LLC | 1,444,518 |
Reported balance
After 2023-07-01 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2023-07-01 · Sale · Disposed 112,838 · Balance 1,444,518 F1: On July 1, 2023, eAperion Partners, LLC exercised a Conversion Warrant to purchase 228,240 shares of RXMD common stock for $2.20 a share. eAperion Partners, LLC paid the exercise price on a cashless basis, resulting in RXMD's withholding of 112,838 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 115,402 shares. F7: The Reporting Person is the sole member and managing member of eAperion Partners LLC. |
| Common StockSEC Table I · non-derivative | IndirectBy eAperion Partners LLC | 1,634,518 |
Reported balance
After 2023-07-01 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2023-07-01 · Other · Acquired 190,000 · Balance 1,634,518 F7: The Reporting Person is the sole member and managing member of eAperion Partners LLC. |
| Common StockSEC Table I · non-derivative | IndirectBy eAperion Partners LLC | 1,540,586 |
Reported balance
After 2023-07-01 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2023-07-01 · Sale · Disposed 93,932 · Balance 1,540,586 F2: On July 1, 2023, eAperion Partners, LLC exercised an Inducement Warrant to purchase 190,000 shares of RXMD common stock for $2.20 a share. eAperion Partners, LLC paid the exercise price on a cashless basis, resulting in RXMD's withholding of 93,932 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 96,068 shares. F7: The Reporting Person is the sole member and managing member of eAperion Partners LLC. |
| Common StockSEC Table I · non-derivative | IndirectBy NextPlat Corp | 2,172,855 |
Last balance in matching sequence
After 2023-07-01 transaction · row 9
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
5 source rowsRow 5 · 2023-07-01 · Other · Acquired 455,000 · Balance 1,995,586 F6: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Row 6 · 2023-07-01 · Sale · Disposed 224,944 · Balance 1,770,642 F3: On July 1, 2023, NextPlat Corp exercised a Warrant to purchase 455,000 shares of RXMD common stock for $2.20 a share. NextPlat Corp paid the exercise price on a cashless basis, resulting in RXMD's withholding of 224,944 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 230,056 shares. F6: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Row 7 · 2023-07-01 · Other · Acquired 340,599 · Balance 2,111,241 F6: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Row 8 · 2023-07-01 · Sale · Disposed 168,386 · Balance 1,942,855 F4: On July 1, 2023, NextPlat Corp exercised a Conversion Warrant to purchase 340,599 shares of RXMD common stock for $2.20 a share. NextPlat Corp paid the exercise price on a cashless basis, resulting in RXMD's withholding of 168,386 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 172,213 shares. F6: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Row 9 · 2023-07-01 · Other · Acquired 230,000 · Balance 2,172,855 F5: On July 1, 2023, NextPlat Corp, exercised a Conversion Warrant to purchase 230,000 shares of RXMD common stock for $2.20 per share. NextPlat Corp paid the exercise price on a cash basis. F6: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
| Common Stock WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $2.20 · Expires 2028-05-09 | IndirectBy eAperion Partners LLC | 0 |
Reported balance
After 2023-07-01 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2023-07-01 · Other · Acquired 228,240 · Balance 0 F7: The Reporting Person is the sole member and managing member of eAperion Partners LLC. |
| Common Stock WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $2.20 · Expires 2026-05-09 | IndirectBy eAperion Partners LLC | 0 |
Reported balance
After 2023-07-01 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2023-07-01 · Other · Acquired 190,000 · Balance 0 F7: The Reporting Person is the sole member and managing member of eAperion Partners LLC. |
| Common Stock WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $2.20 · Expires 2026-05-09 | IndirectBy NextPlat Corp | 0 |
Reported balance
After 2023-07-01 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2023-07-01 · Other · Acquired 455,000 · Balance 0 F6: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
| Common Stock WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $2.20 · Expires 2026-05-09 | IndirectBy NextPlat Corp | 0 |
Reported balance
After 2023-07-01 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2023-07-01 · Other · Acquired 340,599 · Balance 0 F6: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
| Common Stock WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $2.20 · Expires 2028-05-09 | IndirectBy NextPlat Corp | 0 |
Reported balance
After 2023-07-01 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2023-07-01 · Other · Acquired 230,000 · Balance 0 F6: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: On July 1, 2023, eAperion Partners, LLC exercised a Conversion Warrant to purchase 228,240 shares of RXMD common stock for $2.20 a share. eAperion Partners, LLC paid the exercise price on a cashless basis, resulting in RXMD's withholding of 112,838 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 115,402 shares.
F2: On July 1, 2023, eAperion Partners, LLC exercised an Inducement Warrant to purchase 190,000 shares of RXMD common stock for $2.20 a share. eAperion Partners, LLC paid the exercise price on a cashless basis, resulting in RXMD's withholding of 93,932 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 96,068 shares.
F3: On July 1, 2023, NextPlat Corp exercised a Warrant to purchase 455,000 shares of RXMD common stock for $2.20 a share. NextPlat Corp paid the exercise price on a cashless basis, resulting in RXMD's withholding of 224,944 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 230,056 shares.
F4: On July 1, 2023, NextPlat Corp exercised a Conversion Warrant to purchase 340,599 shares of RXMD common stock for $2.20 a share. NextPlat Corp paid the exercise price on a cashless basis, resulting in RXMD's withholding of 168,386 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 172,213 shares.
F5: On July 1, 2023, NextPlat Corp, exercised a Conversion Warrant to purchase 230,000 shares of RXMD common stock for $2.20 per share. NextPlat Corp paid the exercise price on a cash basis.
F6: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F7: The Reporting Person is the sole member and managing member of eAperion Partners LLC.
F8: Includes 18,261 shares of common stock directly held by the Reporting Person; 1,071,251 shares of common stock held indirectly by NextPlat Corp., of which the Reporting Person is the Chief Executive Officer; and 239,604 shares of common stock held indirectly by eAperion Partners LLC, of which the Reporting person is the sole member and managing member.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2024 Filed Oct 4, 2024 14:27 UTC | NextPlat Corp NXPL · Entity 7521 | GrantEmployee Stock Option (right to buy) · Derivative | 233,682 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0001437749-24-030667 · rdgdoc.xml · derivative · entry 4 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 233,682 Underlying: Common Stock · 233,682 shares Expires 2032-09-13 F5 · derivative.exercise_date: In connection with the Merger, the Report Person received stock options to acquire 233,682 shares of the Issuer's common stock in exchange for stock options to acquire 157,203 shares of Progressive Care Inc. The options are fully vested. Read SEC document |
| October 01, 2024 Filed Oct 4, 2024 14:27 UTC | NextPlat Corp NXPL · Entity 7521 | GrantCommon Stock | 687,038 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-030667 · rdgdoc.xml · nonDerivative · entry 2 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · eAperion Partners LLC Disclosed balance after: 2,990,252 F2 · price: In connection with the Merger, the Reporting Person indirectly received 687,038 shares of the Issuer's common stock in exchange for 462,185 shares of Progressive Care Inc. through eAperion Partners LLC. On the effective date of the Merger, the Issuer's Per Share Value was $1.48, which is the daily volume weighted average price of the Issuer's common stock for the 20-trading day period ended on the trading day immediately preceding the date of the Merger Agreement on Nasdaq. F3 · ownership.nature: Mr. Fernandez is the sole member and managing partner of eAperion Partners LLC and has voting and dispotive power over the reported shares. Read SEC document |
| October 01, 2024 Filed Oct 4, 2024 14:27 UTC | NextPlat Corp NXPL · Entity 7521 | GrantCommon Stock | 27,145 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-030667 · rdgdoc.xml · nonDerivative · entry 1 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,576,598 F1 · price: On October 1, 2024, the Reporting Person received 27,145 shares of the Issuer's common stock in exchange for 18,261 shares of Progressive Care Inc. in connection with the merger of Progressive Care Inc. into the Issuer (the "Merger"). On the effective date of the Merger, the Issuer's Per Share Value was $1.48, which is the daily volume weighted average price of the Issuer's common stock for the 20-trading day period ended on the trading day immediately preceding the date of the Merger Agreement on Nasdaq. Read SEC document |
| July 01, 2023 Filed Oct 20, 2023 12:04 UTC | Progressive Care Inc. RXMD · Entity 108817 | OtherCommon Stock Warrant · Derivative | 230,000 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001437749-23-028657 · rdgdoc.xml · derivative · entry 14 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By NextPlat Corp Disclosed balance after: 0 Underlying: Common Stock · 230,000 shares Expires 2028-05-09 F6 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| July 01, 2023 Filed Oct 20, 2023 12:04 UTC | Progressive Care Inc. RXMD · Entity 108817 | OtherCommon Stock Warrant · Derivative | 340,599 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001437749-23-028657 · rdgdoc.xml · derivative · entry 13 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By NextPlat Corp Disclosed balance after: 0 Underlying: Common Stock · 340,599 shares Expires 2026-05-09 F6 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| July 01, 2023 Filed Oct 20, 2023 12:04 UTC | Progressive Care Inc. RXMD · Entity 108817 | OtherCommon Stock Warrant · Derivative | 455,000 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001437749-23-028657 · rdgdoc.xml · derivative · entry 12 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By NextPlat Corp Disclosed balance after: 0 Underlying: Common Stock · 455,000 shares Expires 2026-05-09 F6 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| July 01, 2023 Filed Oct 20, 2023 12:04 UTC | Progressive Care Inc. RXMD · Entity 108817 | OtherCommon Stock Warrant · Derivative | 190,000 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001437749-23-028657 · rdgdoc.xml · derivative · entry 11 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By eAperion Partners LLC Disclosed balance after: 0 Underlying: Common Stock · 190,000 shares Expires 2026-05-09 F7 · ownership.nature: The Reporting Person is the sole member and managing member of eAperion Partners LLC. Read SEC document |
| July 01, 2023 Filed Oct 20, 2023 12:04 UTC | Progressive Care Inc. RXMD · Entity 108817 | OtherCommon Stock Warrant · Derivative | 228,240 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001437749-23-028657 · rdgdoc.xml · derivative · entry 10 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By eAperion Partners LLC Disclosed balance after: 0 Underlying: Common Stock · 228,240 shares Expires 2028-05-09 F7 · ownership.nature: The Reporting Person is the sole member and managing member of eAperion Partners LLC. Read SEC document |
| July 01, 2023 Filed Oct 20, 2023 12:04 UTC | Progressive Care Inc. RXMD · Entity 108817 | OtherCommon Stock | 230,000 | $2.20 | $506,000.00 |
DisclosureSEC source: 0001437749-23-028657 · rdgdoc.xml · nonDerivative · entry 9 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By NextPlat Corp Disclosed balance after: 2,172,855 F5 · kind: On July 1, 2023, NextPlat Corp, exercised a Conversion Warrant to purchase 230,000 shares of RXMD common stock for $2.20 per share. NextPlat Corp paid the exercise price on a cash basis. F6 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| July 01, 2023 Filed Oct 20, 2023 12:04 UTC | Progressive Care Inc. RXMD · Entity 108817 | SaleCommon Stock | 168,386 | $4.45 | $749,317.70 |
DisclosureSEC source: 0001437749-23-028657 · rdgdoc.xml · nonDerivative · entry 8 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By NextPlat Corp Disclosed balance after: 1,942,855 F4 · kind: On July 1, 2023, NextPlat Corp exercised a Conversion Warrant to purchase 340,599 shares of RXMD common stock for $2.20 a share. NextPlat Corp paid the exercise price on a cashless basis, resulting in RXMD's withholding of 168,386 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 172,213 shares. F6 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| July 01, 2023 Filed Oct 20, 2023 12:04 UTC | Progressive Care Inc. RXMD · Entity 108817 | OtherCommon Stock | 340,599 | $2.20 | $749,317.80 |
DisclosureSEC source: 0001437749-23-028657 · rdgdoc.xml · nonDerivative · entry 7 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By NextPlat Corp Disclosed balance after: 2,111,241 F6 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| July 01, 2023 Filed Oct 20, 2023 12:04 UTC | Progressive Care Inc. RXMD · Entity 108817 | SaleCommon Stock | 224,944 | $4.45 | $1,001,000.80 |
DisclosureSEC source: 0001437749-23-028657 · rdgdoc.xml · nonDerivative · entry 6 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By NextPlat Corp Disclosed balance after: 1,770,642 F3 · kind: On July 1, 2023, NextPlat Corp exercised a Warrant to purchase 455,000 shares of RXMD common stock for $2.20 a share. NextPlat Corp paid the exercise price on a cashless basis, resulting in RXMD's withholding of 224,944 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 230,056 shares. F6 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| July 01, 2023 Filed Oct 20, 2023 12:04 UTC | Progressive Care Inc. RXMD · Entity 108817 | OtherCommon Stock | 455,000 | $2.20 | $1,001,000.00 |
DisclosureSEC source: 0001437749-23-028657 · rdgdoc.xml · nonDerivative · entry 5 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By NextPlat Corp Disclosed balance after: 1,995,586 F6 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| July 01, 2023 Filed Oct 20, 2023 12:04 UTC | Progressive Care Inc. RXMD · Entity 108817 | SaleCommon Stock | 93,932 | $4.45 | $417,997.40 |
DisclosureSEC source: 0001437749-23-028657 · rdgdoc.xml · nonDerivative · entry 4 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By eAperion Partners LLC Disclosed balance after: 1,540,586 F2 · kind: On July 1, 2023, eAperion Partners, LLC exercised an Inducement Warrant to purchase 190,000 shares of RXMD common stock for $2.20 a share. eAperion Partners, LLC paid the exercise price on a cashless basis, resulting in RXMD's withholding of 93,932 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 96,068 shares. F7 · ownership.nature: The Reporting Person is the sole member and managing member of eAperion Partners LLC. Read SEC document |
| July 01, 2023 Filed Oct 20, 2023 12:04 UTC | Progressive Care Inc. RXMD · Entity 108817 | OtherCommon Stock | 190,000 | $2.20 | $418,000.00 |
DisclosureSEC source: 0001437749-23-028657 · rdgdoc.xml · nonDerivative · entry 3 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By eAperion Partners LLC Disclosed balance after: 1,634,518 F7 · ownership.nature: The Reporting Person is the sole member and managing member of eAperion Partners LLC. Read SEC document |
| July 01, 2023 Filed Oct 20, 2023 12:04 UTC | Progressive Care Inc. RXMD · Entity 108817 | SaleCommon Stock | 112,838 | $4.45 | $502,129.10 |
DisclosureSEC source: 0001437749-23-028657 · rdgdoc.xml · nonDerivative · entry 2 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By eAperion Partners LLC Disclosed balance after: 1,444,518 F1 · kind: On July 1, 2023, eAperion Partners, LLC exercised a Conversion Warrant to purchase 228,240 shares of RXMD common stock for $2.20 a share. eAperion Partners, LLC paid the exercise price on a cashless basis, resulting in RXMD's withholding of 112,838 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 115,402 shares. F7 · ownership.nature: The Reporting Person is the sole member and managing member of eAperion Partners LLC. Read SEC document |
| July 01, 2023 Filed Oct 20, 2023 12:04 UTC | Progressive Care Inc. RXMD · Entity 108817 | OtherCommon Stock | 228,240 | $2.20 | $502,128.00 |
DisclosureSEC source: 0001437749-23-028657 · rdgdoc.xml · nonDerivative · entry 1 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By eAperion Partners LLC Disclosed balance after: 1,557,356 F8 · balance_after: Includes 18,261 shares of common stock directly held by the Reporting Person; 1,071,251 shares of common stock held indirectly by NextPlat Corp., of which the Reporting Person is the Chief Executive Officer; and 239,604 shares of common stock held indirectly by eAperion Partners LLC, of which the Reporting person is the sole member and managing member. F7 · ownership.nature: The Reporting Person is the sole member and managing member of eAperion Partners LLC. Read SEC document |
| May 09, 2023 Filed Jun 30, 2023 17:34 UTC | Progressive Care Inc. RXMD · Entity 108817 | PurchaseCommon Stock Warrant · Derivative | 570,599 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001493152-23-023195 · ownership.xml · derivative · entry 9 Fernandez Charles M. · CIK 0001509529 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By NextPlat Corp Disclosed balance after: 798,839 Underlying: Common Stock · 570,599 shares Expires 2028-05-09 F2 · price: Pursuant to the Debt Conversion Agreement dated May 9, 2023, Issuer agreed to issue one warrant for a number of shares equal to the number of conversion shares issued to the Reporting Person. The warrants have a five-year term, are immediately exercisable, and have an exercise price of $2.20. F2 · derivative.underlying_shares: Pursuant to the Debt Conversion Agreement dated May 9, 2023, Issuer agreed to issue one warrant for a number of shares equal to the number of conversion shares issued to the Reporting Person. The warrants have a five-year term, are immediately exercisable, and have an exercise price of $2.20. F6 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| May 09, 2023 Filed Jun 30, 2023 17:34 UTC | Progressive Care Inc. RXMD · Entity 108817 | ConversionConvertible Note · Derivative | Not disclosed | $0.00 Strike: $2.20 | $1,255,316.75 |
DisclosureSEC source: 0001493152-23-023195 · ownership.xml · derivative · entry 8 Fernandez Charles M. · CIK 0001509529 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By NextPlat Corp Disclosed balance after: 0 Underlying: Common Stock · 570,599 shares Expires 2027-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.underlying_shares: On May 9, 2023, the Reporting Person and NextPlat Corp entered into a Debt Conversion Agreement whereby Issuer issued 228,240 shares of the Issuer's common stock to eAperion Partners LLC, an entity wholly owned by the Reporting Person, and 570,599 shares of the Issuer's common stock to NextPlat Corp upon conversion of the Reporting Person's share of outstanding principal and accrued and unpaid interest of a Secured Promissory Note dated September 2, 2022, at a conversion price of $2.20 per share. F6 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| May 09, 2023 Filed Jun 30, 2023 17:34 UTC | Progressive Care Inc. RXMD · Entity 108817 | PurchaseCommon Stock Warrant · Derivative | 455,000 | $1,000,000.00 Strike: $2.20 | $455,000,000,000.00 |
DisclosureSEC source: 0001493152-23-023195 · ownership.xml · derivative · entry 7 Fernandez Charles M. · CIK 0001509529 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By NextPlat Corp Disclosed balance after: 645,000 Underlying: Common Stock · 455,000 shares Expires 2026-05-09 F4 · derivative.exercise_date: On May 5, 2023, the Issuer entered into a Securities Purchase Agreement with NextPlat Corp, whereby NextPlat Corp. agreed to purchase 455,000 units of securities, consisting of one share of common stock and one warrant. Each warrant is exercisable at $2.20 per share. The warrants are immediately exercisable and have a term of three years. F6 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| May 09, 2023 Filed Jun 30, 2023 17:34 UTC | Progressive Care Inc. RXMD · Entity 108817 | PurchaseCommon Stock Warrant · Derivative | 190,000 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001493152-23-023195 · ownership.xml · derivative · entry 6 Fernandez Charles M. · CIK 0001509529 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By eAperion Partners LLC Disclosed balance after: 190,000 Underlying: Common Stock · 190,000 shares Expires 2026-05-09 F3 · price: On May 9, 2023, the Reporting Person was issued warrants to purchase 190,000 shares of common stock of the Issuer as an inducement to approve the transaction contemplated by the Securities Purchase Agreement dated May 5, 2023. The warrants have a three-year term, are immediately exercisable, and have an exercise price of $2.20. F3 · derivative.underlying_shares: On May 9, 2023, the Reporting Person was issued warrants to purchase 190,000 shares of common stock of the Issuer as an inducement to approve the transaction contemplated by the Securities Purchase Agreement dated May 5, 2023. The warrants have a three-year term, are immediately exercisable, and have an exercise price of $2.20. F7 · ownership.nature: The Reporting Person is the sole member and managing member of eAperion Partners LLC. Read SEC document |
| May 09, 2023 Filed Jun 30, 2023 17:34 UTC | Progressive Care Inc. RXMD · Entity 108817 | PurchaseCommon Stock Warrant · Derivative | 228,240 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001493152-23-023195 · ownership.xml · derivative · entry 5 Fernandez Charles M. · CIK 0001509529 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By eAperion Partners LLC Disclosed balance after: 228,240 Underlying: Common Stock · 228,240 shares Expires 2028-05-09 F2 · price: Pursuant to the Debt Conversion Agreement dated May 9, 2023, Issuer agreed to issue one warrant for a number of shares equal to the number of conversion shares issued to the Reporting Person. The warrants have a five-year term, are immediately exercisable, and have an exercise price of $2.20. F2 · derivative.underlying_shares: Pursuant to the Debt Conversion Agreement dated May 9, 2023, Issuer agreed to issue one warrant for a number of shares equal to the number of conversion shares issued to the Reporting Person. The warrants have a five-year term, are immediately exercisable, and have an exercise price of $2.20. F7 · ownership.nature: The Reporting Person is the sole member and managing member of eAperion Partners LLC. Read SEC document |
| May 09, 2023 Filed Jun 30, 2023 17:34 UTC | Progressive Care Inc. RXMD · Entity 108817 | ConversionConvertible Note · Derivative | Not disclosed | $0.00 Strike: $2.20 | $502,126.70 |
DisclosureSEC source: 0001493152-23-023195 · ownership.xml · derivative · entry 4 Fernandez Charles M. · CIK 0001509529 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By eAperion Partners LLC Disclosed balance after: 0 Underlying: Common Stock · 228,240 shares Expires 2027-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · ownership.nature: The Reporting Person is the sole member and managing member of eAperion Partners LLC. Read SEC document |
| May 09, 2023 Filed Jun 30, 2023 17:34 UTC | Progressive Care Inc. RXMD · Entity 108817 | ConversionCommon Stock | 570,599 | $2.20 | $1,255,317.80 |
DisclosureSEC source: 0001493152-23-023195 · ownership.xml · nonDerivative · entry 3 Fernandez Charles M. · CIK 0001509529 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By NextPlat Corp Disclosed balance after: 1,329,116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On May 9, 2023, the Reporting Person and NextPlat Corp entered into a Debt Conversion Agreement whereby Issuer issued 228,240 shares of the Issuer's common stock to eAperion Partners LLC, an entity wholly owned by the Reporting Person, and 570,599 shares of the Issuer's common stock to NextPlat Corp upon conversion of the Reporting Person's share of outstanding principal and accrued and unpaid interest of a Secured Promissory Note dated September 2, 2022, at a conversion price of $2.20 per share. F8 · balance_after: Includes 18,261 shares of common stock directly held by the Reporting Person; 45,652 shares of common stock held indirectly by NextPlat Corp., of which the Reporting Person is the Chief Executive Officer; and 11,364 shares of common stock held indirectly by eAperion Partners LLC, of which the Reporting person is the sole member and managing member. F6 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| May 09, 2023 Filed Jun 30, 2023 17:34 UTC | Progressive Care Inc. RXMD · Entity 108817 | PurchaseCommon Stock | 455,000 | $2.20 | $1,001,000.00 |
DisclosureSEC source: 0001493152-23-023195 · ownership.xml · nonDerivative · entry 2 Fernandez Charles M. · CIK 0001509529 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By NextPlat Corp Disclosed balance after: 758,517 F4 · shares: On May 5, 2023, the Issuer entered into a Securities Purchase Agreement with NextPlat Corp, whereby NextPlat Corp. agreed to purchase 455,000 units of securities, consisting of one share of common stock and one warrant. Each warrant is exercisable at $2.20 per share. The warrants are immediately exercisable and have a term of three years. F8 · balance_after: Includes 18,261 shares of common stock directly held by the Reporting Person; 45,652 shares of common stock held indirectly by NextPlat Corp., of which the Reporting Person is the Chief Executive Officer; and 11,364 shares of common stock held indirectly by eAperion Partners LLC, of which the Reporting person is the sole member and managing member. F6 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| May 09, 2023 Filed Jun 30, 2023 17:34 UTC | Progressive Care Inc. RXMD · Entity 108817 | ConversionCommon Stock | 228,240 | $2.20 | $502,128.00 |
DisclosureSEC source: 0001493152-23-023195 · ownership.xml · nonDerivative · entry 1 Fernandez Charles M. · CIK 0001509529 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By eAperion Partners LLC Disclosed balance after: 303,517 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On May 9, 2023, the Reporting Person and NextPlat Corp entered into a Debt Conversion Agreement whereby Issuer issued 228,240 shares of the Issuer's common stock to eAperion Partners LLC, an entity wholly owned by the Reporting Person, and 570,599 shares of the Issuer's common stock to NextPlat Corp upon conversion of the Reporting Person's share of outstanding principal and accrued and unpaid interest of a Secured Promissory Note dated September 2, 2022, at a conversion price of $2.20 per share. F8 · balance_after: Includes 18,261 shares of common stock directly held by the Reporting Person; 45,652 shares of common stock held indirectly by NextPlat Corp., of which the Reporting Person is the Chief Executive Officer; and 11,364 shares of common stock held indirectly by eAperion Partners LLC, of which the Reporting person is the sole member and managing member. F7 · ownership.nature: The Reporting Person is the sole member and managing member of eAperion Partners LLC. Read SEC document |
| April 14, 2023 Filed Apr 23, 2024 21:24 UTC | NextPlat Corp NXPL · Entity 7521 | GrantStock Option · Derivative | 200,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-012878 · rdgdoc.xml · derivative · entry 5 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By eAperion Partners, LLC Disclosed balance after: 370,000 Underlying: Common Stock, par value $0.0001 per share · 200,000 shares Expires 2028-04-25 F4 · kind: On April 14, 2023, the reporting person was granted options to purchase up to 200,000 shares of the Issuer's common stock pursuant to a Stock Option Agreement dated April 14, 2023, of which the shares of common stock vested immediately on the Grant Date. Read SEC document |
| April 07, 2023 Filed Apr 23, 2024 21:24 UTC | NextPlat Corp NXPL · Entity 7521 | GrantStock Option · Derivative | 25,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-012878 · rdgdoc.xml · derivative · entry 4 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By wife Disclosed balance after: 370,000 Underlying: Common Stock, par value $0.0001 per share · 25,000 shares Expires 2028-04-25 F3 · kind: The reporting person's wife, an employee of the Issuer, was granted options to purchase up to 25,000 shares of the Issuer's common stock pursuant to a Stock Option Agreement dated April 7, 2023, of which one third of the shares of common stock vested immediately on the Grant Date, with options to purchase an additional third of the shares of common stock vesting on the one-year anniversary of the Grant Date, and options to purchase the remaining third of the shares of common stock vesting on the second-year anniversary of the Grant Date. F3 · derivative.exercise_date: The reporting person's wife, an employee of the Issuer, was granted options to purchase up to 25,000 shares of the Issuer's common stock pursuant to a Stock Option Agreement dated April 7, 2023, of which one third of the shares of common stock vested immediately on the Grant Date, with options to purchase an additional third of the shares of common stock vesting on the one-year anniversary of the Grant Date, and options to purchase the remaining third of the shares of common stock vesting on the second-year anniversary of the Grant Date. Read SEC document |
| April 07, 2023 Filed Apr 23, 2024 21:24 UTC | NextPlat Corp NXPL · Entity 7521 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-012878 · rdgdoc.xml · nonDerivative · entry 3 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By wife Disclosed balance after: 3,677,667 F1 · kind: On April 7, 2023, the reporting person's wife, and employee of the Issuer, entered into a Restricted Stock Award Agreement with the Issuer, pursuant to which she was granted 25,000 shares of the Issuer's common stock. The restricted stock vested immediately upon issuance. F2 · balance_after: Includes 3,652,667 shares of common stock held indirectly by eAperion Partners, LLC, of which Mr. Fernandez is the owner and manager. Read SEC document |
| April 05, 2023 Filed Apr 8, 2023 00:15 UTC | NextPlat Corp NXPL · Entity 7521 | GrantCommon Stock | 325,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-011614 · ownership.xml · nonDerivative · entry 1 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Held by eApeiron Partners, LLC Disclosed balance after: 3,452,667 F1 · shares: On April 3, 2023, the Compensation Committee and Board of the Issuer approved a restricted stock award for 325,000 shares of common stock to Mr. Fernandez under the Issuer's 2021 Incentive Award Plan. The restricted shares were then issued on April 5, 2023. The shares are fully vested. F2 · balance_after: Does not include 400,000 shares of restricted stock awarded on May 28, 2021, that vests in two equal tranches on the second and third year anniversaries of the grant date. F3 · ownership.nature: Mr. Fernandez is the sole member and managing partner of eAperion Partners LLC. Read SEC document |
| April 03, 2023 Filed Apr 23, 2024 21:24 UTC | NextPlat Corp NXPL · Entity 7521 | GrantCommon Stock | 325,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-012878 · rdgdoc.xml · nonDerivative · entry 2 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,677,667 F2 · balance_after: Includes 3,652,667 shares of common stock held indirectly by eAperion Partners, LLC, of which Mr. Fernandez is the owner and manager. Read SEC document |
| February 28, 2023 Filed Apr 23, 2024 21:24 UTC | NextPlat Corp NXPL · Entity 7521 | GrantCommon Stock | 39,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-012878 · rdgdoc.xml · nonDerivative · entry 1 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,677,667 F2 · balance_after: Includes 3,652,667 shares of common stock held indirectly by eAperion Partners, LLC, of which Mr. Fernandez is the owner and manager. Read SEC document |
| December 14, 2022 Filed Dec 20, 2022 17:47 UTC | NextPlat Corp NXPL · Entity 7521 | PurchaseCommon Stock Warrants · Derivative | 1,085,714 | Not disclosed Strike: $1.75 | Not disclosed |
DisclosureSEC source: 0001493152-22-035961 · ownership.xml · derivative · entry 2 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by eApeiron Partners, LLC Disclosed balance after: 1,685,714 Underlying: Common Stock · 1,085,714 shares Expires 2025-12-14 F2 · shares: On December 14, 2022 eAperion Partners LLC purchased 1,085,714 units from the Issuer in a private placement for $1.75 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock of the Issuer. The warrants underlying units are immediately exercisable. F2 · price: On December 14, 2022 eAperion Partners LLC purchased 1,085,714 units from the Issuer in a private placement for $1.75 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock of the Issuer. The warrants underlying units are immediately exercisable. F1 · ownership.nature: Mr. Fernandez is the sole member and managing partner of eAperion Partners LLC. Read SEC document |
| December 14, 2022 Filed Dec 20, 2022 17:47 UTC | NextPlat Corp NXPL · Entity 7521 | PurchaseCommon Stock | 1,085,714 | $1,899,999.50 | $2,062,856,057,143.00 |
DisclosureSEC source: 0001493152-22-035961 · ownership.xml · nonDerivative · entry 1 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by eApeiron Partners, LLC Disclosed balance after: 3,658,667 F2 · shares: On December 14, 2022 eAperion Partners LLC purchased 1,085,714 units from the Issuer in a private placement for $1.75 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock of the Issuer. The warrants underlying units are immediately exercisable. F1 · ownership.nature: Mr. Fernandez is the sole member and managing partner of eAperion Partners LLC. Read SEC document |
| November 16, 2022 Filed Jun 30, 2023 17:34 UTC | Progressive Care Inc. RXMD · Entity 108817 | ConversionConvertible Note · Derivative | Not disclosed | Not disclosed Strike: $2.20 | $10,000,000.00 |
DisclosureSEC source: 0001493152-23-023195 · ownership.xml · derivative · entry 11 Fernandez Charles M. · CIK 0001509529 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By NextPlat Corp Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires 2025-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: On May 9, 2023, NextPlat Corp entered into a First Amendment to the Securities Purchase Agreement dated November 16, 2022 (the "Debenture Purchase Agreement"), resulting in the cancellation of the "old" convertible note and the purchase of a replacement convertible note. Pursuant to the Amendment, NextPlat Corp agreed to amend the Debenture Purchase Agreement and the Form of Debenture to increase the conversion price to $2.20 per share. The debentures are convertible at any time, upon NextPlat Corp.'s election, to shares of the Issuer's common stock. No debentures have been purchased to date. F5 · underlyingValue: On May 9, 2023, NextPlat Corp entered into a First Amendment to the Securities Purchase Agreement dated November 16, 2022 (the "Debenture Purchase Agreement"), resulting in the cancellation of the "old" convertible note and the purchase of a replacement convertible note. Pursuant to the Amendment, NextPlat Corp agreed to amend the Debenture Purchase Agreement and the Form of Debenture to increase the conversion price to $2.20 per share. The debentures are convertible at any time, upon NextPlat Corp.'s election, to shares of the Issuer's common stock. No debentures have been purchased to date. F6 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 16, 2022 Filed Jun 30, 2023 17:34 UTC | Progressive Care Inc. RXMD · Entity 108817 | ConversionConvertible Note · Derivative | Not disclosed | Not disclosed Strike: $0.03 | $10,000,000.00 |
DisclosureSEC source: 0001493152-23-023195 · ownership.xml · derivative · entry 10 Fernandez Charles M. · CIK 0001509529 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By NextPlat Corp Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires 2025-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: On May 9, 2023, NextPlat Corp entered into a First Amendment to the Securities Purchase Agreement dated November 16, 2022 (the "Debenture Purchase Agreement"), resulting in the cancellation of the "old" convertible note and the purchase of a replacement convertible note. Pursuant to the Amendment, NextPlat Corp agreed to amend the Debenture Purchase Agreement and the Form of Debenture to increase the conversion price to $2.20 per share. The debentures are convertible at any time, upon NextPlat Corp.'s election, to shares of the Issuer's common stock. No debentures have been purchased to date. F5 · underlyingValue: On May 9, 2023, NextPlat Corp entered into a First Amendment to the Securities Purchase Agreement dated November 16, 2022 (the "Debenture Purchase Agreement"), resulting in the cancellation of the "old" convertible note and the purchase of a replacement convertible note. Pursuant to the Amendment, NextPlat Corp agreed to amend the Debenture Purchase Agreement and the Form of Debenture to increase the conversion price to $2.20 per share. The debentures are convertible at any time, upon NextPlat Corp.'s election, to shares of the Issuer's common stock. No debentures have been purchased to date. F6 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| September 20, 2022 Filed Oct 6, 2022 13:15 UTC | NextPlat Corp NXPL · Entity 7521 | GrantCommon Stock, par value $0.0001 per share | 116,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-027769 · ownership.xml · nonDerivative · entry 2 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Shares held by eApeiron Partners, LLC Disclosed balance after: 1,865,453 F3 · balance_after: Includes 316,000 shares of restricted common stock held by eApeiron Partners LLC, of which Mr. Fernandez is sole and managing partner. F1 · ownership.nature: Mr. Fernandez is the sole member and managing partner of eApeiron Partners LLC. Read SEC document |
| September 13, 2022 Filed Oct 18, 2022 10:45 UTC | Progressive Care Inc. RXMD · Entity 108817 | GrantStock Options · Derivative | 31,440,555 | $0.00 Strike: $0.02 | $0.00 |
DisclosureSEC source: 0001493152-22-028631 · ownership.xml · derivative · entry 1 Fernandez Charles M. · CIK 0001509529 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 716,380,553 Underlying: Common Stock · 31,440,555 shares Expires 2032-09-13 F1 · derivative.exercise_date: Options to purchase up to 12,576,222 Common Shares are fully vested upon Grant Date; Options to purchase up to an additional 6,288,111 Common Shares become vested upon the first Trading Day following the date on which the Company's market capitalization is $50 million or more for five consecutive Trading Days; options to purchase up to an additional 6,288,111 Common Shares become fully vested on the first Trading Day following the date on which the Company's market capitalization is $100 million or more for five consecutive Trading Days; and options to purchase up to an additional 6,288,111 Common Shares become fully vested on the first Trading Day following the date on which the Company's market capitalization is $200 million or more for five consecutive Trading Days. F2 · balance_after: Includes 660,671,427 derivative securities owned by NextPlat Corp. As Chairman and Chief Executive Officer of NextPlat Corp, Mr. Fernandez has voting or investment control over these securities. For the avoidance of doubt, Mr. Fernandez expressly disclaims ownership of the Issuer's securities owned by NextPlat. Read SEC document |
| July 22, 2022 Filed Oct 6, 2022 13:15 UTC | NextPlat Corp NXPL · Entity 7521 | GrantCommon Stock, par value $0.0001 per share | 200,000 | $5.00 | $1,000,000.00 |
DisclosureSEC source: 0001493152-22-027769 · ownership.xml · nonDerivative · entry 1 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Shares held by eApeiron Partners, LLC. Disclosed balance after: 1,749,453 F2 · balance_after: Includes 200,000 shares of common stock held by eApeiron Partners LLC, of which Mr. Fernandez is sole member and managing partner. F1 · ownership.nature: Mr. Fernandez is the sole member and managing partner of eApeiron Partners LLC. Read SEC document |
| July 01, 2022 Filed Oct 6, 2022 13:15 UTC | NextPlat Corp NXPL · Entity 7521 | GrantStock Options · Derivative | 70,000 | $0.00 Strike: $2.13 | $0.00 |
DisclosureSEC source: 0001493152-22-027769 · ownership.xml · derivative · entry 3 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 707,500 Underlying: Common Stock · 70,000 shares Expires 2032-07-01 F5 · price: The stock options were granted as an equity incentive award. F4 · derivative.underlying_shares: On July 1, 2022, Mr. Fernandez was granted an option to purchase 70,000 shares of common stock. The option was fully vested, issued outside of any equity compensation plan, with an exercise price of $2.13, and a term of ten years. Read SEC document |
| January 05, 2022 Filed Jan 6, 2022 20:11 UTC | NextPlat Corp OSAT · Entity 7521 | PurchaseCommon Stock, par value $0.0001 | 679,013 | $3.24 | $2,200,002.12 |
DisclosureSEC source: 0001493152-22-000548 · ownership.xml · nonDerivative · entry 1 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,686,953 F1 · shares: Represents 679,013 shares of the Issuer's common stock acquired by the Reporting Person from the Issuer in a private placement transaction that closed on January 5, 2022, pursuant to a Securities Purchase Agreement dated December 31, 2021. The purchase price for the acquired shares was $3.24 per share, which is the closing transaction price of the Issuer's common stock reported by Nasdaq on December 31, 2021. F2 · balance_after: Includes a restricted stock award for 275,000 shares of common stock that was effective 12/16/21 (the "Grant Date"). One half of the award (137,500 shares) was fully vested and issued on Grant Date and the remaining half (137,500 shares) will vest and be issued on the one year anniversary of the Grant Date. The award was granted pursuant to the Orbsat Corp 2021 Incentive Award Plan. Read SEC document |
| December 16, 2021 Filed Dec 20, 2021 22:16 UTC | NextPlat Corp OSAT · Entity 7521 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $3.81 | $0.00 |
DisclosureSEC source: 0001493152-21-032067 · ownership.xml · derivative · entry 4 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2031-12-16 F4 · date: The grant of these options was effective 12/16/2021 (the "Grant Date"), the date Issuer's stockholders approved the Orbsat Corp 2021 Incentive Award Plan. The award was granted pursuant to the Orbsat Corp 2021 Incentive Award Plan. One half of the award will be fully vested on Grant Date and the remaining half will vest on the one year anniversary of the Grant Date. F4 · derivative.exercise_date: The grant of these options was effective 12/16/2021 (the "Grant Date"), the date Issuer's stockholders approved the Orbsat Corp 2021 Incentive Award Plan. The award was granted pursuant to the Orbsat Corp 2021 Incentive Award Plan. One half of the award will be fully vested on Grant Date and the remaining half will vest on the one year anniversary of the Grant Date. Read SEC document |
| December 16, 2021 Filed Dec 20, 2021 22:16 UTC | NextPlat Corp OSAT · Entity 7521 | GrantCommon Stock, par value $0.0001 | 275,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-032067 · ownership.xml · nonDerivative · entry 2 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,007,940 F2 · shares: Represents a restricted stock award that was effective 12/16/21 (the "Grant Date"), the date Issuer's stockholders approved the Orbsat Corp 2021 Incentive Award Plan. One half of the award, (137,500 shares), will be fully vested and issued on Grant Date and the remaining half (137,500 shares) will vest and be issued on the one year anniversary of the Grant Date. The award was granted pursuant to the Orbsat Corp 2021 Incentive Award Plan. Read SEC document |
| December 16, 2021 Filed Dec 20, 2021 22:16 UTC | NextPlat Corp OSAT · Entity 7521 | GrantCommon Stock, par value $0.0001 | 101,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-032067 · ownership.xml · nonDerivative · entry 1 Fernandez Charles M. · CIK 0001509529 · Director · Chairman & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 732,940 F1 · shares: Represents a fully vested restricted stock award that was effective 12/16/2021, the date the Issuer's stockholders approved the Orbsat Corp 2020 Equity Incentive Plan. The award was granted pursuant to the Orbsat Corp 2020 Equity Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.